For the Inventor, By the Inventor

Enter assignee name

Jenapharm Gmbh & Co. Kg

USPTO Granted Patents = 26

Forward Citations = 438

Loading Chart...

Loading Chart...

67 inventors (with patents filed for the assignee):

Michael Dittgen (9 out of 19 patents)

Michael Oettel (9 out of 21 patents)

Walter Elger (8 out of 122 patents)

4. Sigfrid Schwarz (7 out of 15 patents)

5. Sabine Fricke (6 out of 10 patents)

6. Birgitt Schneider (6 out of 17 patents)

7. Carsten Timpe (5 out of 5 patents)

8. Peter Droescher (4 out of 14 patents)

9. Bernd Menzenbach (4 out of 14 patents)

10. Sven Ring (3 out of 27 patents)

11. Detlef Grawe (3 out of 11 patents)

12. Gerd Schubert (3 out of 16 patents)

13. Gudrun Reddersen (3 out of 9 patents)

14. Lothar Sobek (3 out of 5 patents)

15. Guenter Kaufmann (3 out of 9 patents)

26 patents: Sort by Forward Citations

1. 6977083 - Bioadhesive tablet containing testosterone/testosterone ester mixtures and method for producing a predetermined testosterone time-release profile with same (2005-12-20),

2. 6902741 - Laminates containing an active substance transdermal system (2005-06-07),

3. 6884793 - Combination preparation for contraception based on natural estrogens (2005-04-26),

4. 6855836 - 17-Methylene steroids, process for their production and pharmaceutical compositions that contain these compounds (2005-02-15),

5. 6815469 - Biodegradable, injectable oligomer-polymer composition (2004-11-09),

6. 6753326 - 14, 15-.&agr;.-methylene equilenine derivatives, methods for producing the same and medicaments containing them (2004-06-22),

7. 6689768 - Pharmaceutical preparations for treating side effects during and/or after GnRHa therapy (2004-02-10),

8. 6670493 - Methods and compositions for treating diseases due to androgen deficiency with glucocorticoid receptor antagonist compounds and new compounds (2003-12-30),

9. 6670350 - Method of administering dienogest in high dosages to reduce the body of the breast and pharmaceutical composition for same (2003-12-30),

10. 6569844 - Pharmaceutical preparations containing estra-1,3,5(10)-triene derivatives (2003-05-27),

11. 6534490 - Unsaturated 14, 15-cyclopropanoandrostanes, method for the production thereof and pharmaceutical preparations containing said compounds (2003-03-18),

12. 6436917 - Non-estrogenic estradiol derivative compounds with anti-oxidative activity (2002-08-20),

13. 6388109 - 14,15-cyclopropano steroids of the 19-norandrostane series, method for the production thereof and pharmaceutical preparations containing said compounds (2002-05-14),

14. 6365582 - S-substitute 11&bgr;-benzaldoxime-estra-4, 9-diene-carbonic acid thiolesters, method for the production thereof and pharmaceutical preparations containing these compounds (2002-04-02),

15. 6303137 - Injectable implant (2001-10-16),

Jenapharm GmbH & Co. KG is a pharmaceutical company based in Jena, Germany. They specialize in the development, production, and marketing of innovative drugs and medical products for various therapeutic areas. With a strong focus on women's health, Jenapharm offers a wide range of contraceptives, hormone therapies, and gynecological drugs. Committed to high-quality standards and continuous research, Jenapharm aims to improve the well-being and health of individuals worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

26 Patents

#15 in Jena

#1,812 in Germany

#24,051 in the World

Jenapharm Gmbh & Co. Kg

Forward Citations = 438

67 inventors:

Michael Dittgen (9 out of 19 patents)

Michael Oettel (9 out of 21 patents)

Walter Elger (8 out of 122 patents)

4. Sigfrid Schwarz (7 out of 15 patents)

5. Sabine Fricke (6 out of 10 patents)

Please report any incorrect information to support@idiyas.com

Loading…